Early Catheter Removal for Urogynecologic Surgery
(CARES2 Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial examines whether removing a catheter at home one day after urogynecologic surgery is as safe and effective as removing it three or four days later. The goal is to determine if earlier removal aids recovery without increasing risks. Women who have undergone prolapse or anti-incontinence surgery and experience difficulty urinating independently may qualify for this study. Participants will either remove their catheter on the first day after surgery or wait until the third or fourth day. As an unphased trial, this study allows participants to contribute to important research that could enhance recovery experiences for future patients.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that early catheter removal is safe for postoperative patients?
Research has shown that early removal of urinary catheters can be safe for patients. One study found that removing catheters at home on the first day after surgery (post-operative day one, or POD1) was as safe in preventing urination difficulties as removing them on the third or fourth day. Thus, the risk of urination issues was similar regardless of when the catheter was removed.
Another study found that earlier removal helped reduce pain from urinary tract infections (UTIs), potentially making recovery more comfortable. While early removal appears safe, individual experiences may vary. Patients should always consult their doctor to determine the best approach for their situation.12345Why are researchers excited about this trial?
Researchers are excited about the early catheter removal technique for urogynecologic surgery because it could significantly reduce the discomfort and risk of infection associated with longer catheter use. Unlike the standard practice, which involves removing catheters on post-operative days 3–4, this new approach suggests removal as early as day 1. This potentially speeds up recovery and improves overall patient comfort without compromising safety.
What evidence suggests that early catheter removal is effective for postoperative urinary retention?
This trial will compare early catheter removal with standard catheter removal following urogynecologic surgery. Studies have shown that removing urinary catheters on the first day after surgery can be as effective as waiting until the third or fourth day. Research indicates that early removal does not increase the risk of urination difficulties compared to later removal. One study found that early removal helped patients leave the hospital sooner, reducing their stay by one to three days. Other research suggests that earlier removal can reduce pain from urinary tract infections (UTIs). Overall, early removal can be a safe and effective option for recovery after urogynecologic surgery.12346
Who Is on the Research Team?
Lauren Tholemeier, MD
Principal Investigator
University of North Carollina at Chapel Hill
Are You a Good Fit for This Trial?
This trial is for women who have had prolapse or anti-incontinence surgery and can't empty their bladder properly before leaving the hospital. It's not for those who don't speak English, are pregnant, needed catheterization before surgery, got urethral injections, or had complications during surgery needing longer catheter use.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment/Intervention
Participants undergo urogynecologic surgery and are randomized to catheter removal on POD1 or POD3-4
Postoperative Monitoring
Participants are monitored for voiding symptoms and complications, with a phone call at week 2 and an office visit at week 6
Follow-up
Participants are monitored for postoperative complications such as UTI or urinary retention
What Are the Treatments Tested in This Trial?
Interventions
- Early catheter removal
Trial Overview
The study tests if patients removing urinary catheters at home one day after urogynecologic surgery is just as good as the standard practice of removal on days three or four by a healthcare provider in an office setting.
How Is the Trial Designed?
2
Treatment groups
Experimental Treatment
Active Control
Participants in this arm will be asked to remove their catheters POD1.
Participants in this arm will be asked to remove their catheters POD3-4.
Find a Clinic Near You
Who Is Running the Clinical Trial?
University of North Carolina, Chapel Hill
Lead Sponsor
Published Research Related to This Trial
Citations
Evaluating the effectiveness of early urethral catheter ...
The primary objective of this study is to evaluate the effectiveness and safety of early urinary catheter removal combined with IC in restoring ...
Early Patient Removal of Urinary Catheters After ...
Randomized, controlled, non-inferiority trial to compare the risk of urinary retention between patient urinary catheter removal on POD1 versus ...
Effect of early removal of urinary catheter on recovery after ...
5 studies revealed that early catheter removal significantly shortened the LOS by an average of 1–3 days (P ≤ 0.001).
Patient Removal of Urinary Catheters After Urogynecologic ...
Postoperative urinary catheter removal by the patient at home was noninferior to office removal when early urinary retention rates were compared.
5.
journals.lww.com
journals.lww.com/md-journal/fulltext/2020/01100/the_timing_of_urinary_catheter_removal_after.71.aspxThe timing of urinary catheter removal after gynecologic...
Dunn et al reported that immediate removal of urinary catheter after gynecologic surgery significantly reduced UTI-associated pain, whereas Chai et al found ...
Impact of early postoperative indwelling urinary catheter ...
One study (6%) found a statistically significant effect between IDUC removal after 6 h and removal the morning after surgery, with 9% and 0% ...
Unbiased Results
We believe in providing patients with all the options.
Your Data Stays Your Data
We only share your information with the clinical trials you're trying to access.
Verified Trials Only
All of our trials are run by licensed doctors, researchers, and healthcare companies.